Clinical trial
Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in…
NCT00152698 · University of Erlangen-Nürnberg Medical School, Other · Withdrawn
Key facts
| NCT number | NCT00152698 |
|---|---|
| Title | Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia |
| Official title | A Randomised, Double-blind, Placebo-controlled, Phase III Trial to Study the Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia |
| Lead sponsor | University of Erlangen-Nürnberg Medical School, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | Irbesartan |
| Enrollment | 0 |
| Start date | Nov 1, 2009 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2009 |
| First posted | Sep 9, 2005 |
| Last update posted | Dec 16, 2024 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: